ATE242638T1 - Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen - Google Patents

Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Info

Publication number
ATE242638T1
ATE242638T1 AT99972540T AT99972540T ATE242638T1 AT E242638 T1 ATE242638 T1 AT E242638T1 AT 99972540 T AT99972540 T AT 99972540T AT 99972540 T AT99972540 T AT 99972540T AT E242638 T1 ATE242638 T1 AT E242638T1
Authority
AT
Austria
Prior art keywords
soy protein
composition
dietary fibers
phytoestrogen
prevention
Prior art date
Application number
AT99972540T
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Application granted granted Critical
Publication of ATE242638T1 publication Critical patent/ATE242638T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99972540T 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen ATE242638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801557 1998-11-25
PCT/IB1999/001997 WO2000030664A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases

Publications (1)

Publication Number Publication Date
ATE242638T1 true ATE242638T1 (de) 2003-06-15

Family

ID=8106042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972540T ATE242638T1 (de) 1998-11-25 1999-11-25 Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen

Country Status (10)

Country Link
US (1) US6509043B1 (de)
EP (1) EP1133307B1 (de)
JP (1) JP2002530346A (de)
AT (1) ATE242638T1 (de)
AU (1) AU1404600A (de)
BR (1) BR9915689A (de)
CA (1) CA2352338A1 (de)
DE (1) DE69908809D1 (de)
HK (1) HK1041634A1 (de)
WO (1) WO2000030664A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2352585A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
US6733815B2 (en) 1999-04-16 2004-05-11 Cargill, Incorporated Food ingredient containing wheat gluten, soy grits and soy flour
JP2002542192A (ja) 1999-04-20 2002-12-10 ボード オブ トラスティース， サザン イリノイ ユニバーシティ イソフラボンで臨床的な疾患を処置する方法
EP1274319B1 (de) 2000-04-14 2009-08-12 Mars, Incorporated Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
EP1443946A2 (de) * 2001-07-03 2004-08-11 Nutri Pharma ASA Soja-enthaltende zusammensetzung und deren verwendung zur prävention und/oder behandlung von verschiedenen krankheiten
AU2003206050A1 (en) * 2002-02-22 2003-09-09 Nutri Pharma Asa Food products comprising soy protein
EP1480525A2 (de) * 2002-02-23 2004-12-01 Nutri Pharma ASA Neue sojaproteinprodukte
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
CN104643057A (zh) * 2002-07-24 2015-05-27 儿童医院医疗中心 含有对映体牛尿酚的组合物和产物及其用途
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
CA2564399A1 (en) * 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
US20050261197A1 (en) * 2004-05-19 2005-11-24 Henry Aoki Coffee bean extract, method of extraction and composition containing the same
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
WO2014145086A2 (en) 2013-03-15 2014-09-18 Galvez Alfredo Flores Products and methods using lunasin-enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
US10946058B2 (en) * 2013-10-11 2021-03-16 Uppala RAJAKARUNA Food additives and methods of making and using same
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders
JP2023088736A (ja) * 2021-12-15 2023-06-27 アクティブペプチド株式会社 Ｃｏｐｄ治療薬およびｃｏｐｄ治療用飲食品

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) * 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
US4557927A (en) 1983-03-10 1985-12-10 Kabushiki Kaisha Hoyashibara Food products and process for producing same
FR2543550B1 (fr) 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
JPS62201882A (ja) 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
US4818558A (en) 1987-08-04 1989-04-04 Worthington Foods, Inc. Fiber/tofu food product and method for making the same
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
EP0656786B2 (de) 1992-05-19 2014-04-23 Novogen Research Pty Ltd Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
DK171752B1 (da) 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
WO1994023716A1 (en) 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
US6140469A (en) 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
CN1055931C (zh) 1993-10-12 2000-08-30 蛋白质技术国际公司 富含糖苷配基异黄酮植物蛋白浓缩物及其制备方法
BR9407822A (pt) 1993-10-12 1997-05-06 Protein Tech Int Processo para produção de um soro de leite coalhado de proteina vegetal enriquecido com aglucono isoflavona soro de leite coalhado enriquecido com aglucono isoflavona proteina de soro de leite coalhado enriquecido com aglucono isoflavona e processo para a recuperação em uma proteina de leite coalhado de pelo mones 50% de uma isoflavona de um material de proteina vegetal
US5320949A (en) 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
CA2173743A1 (en) 1993-10-12 1995-04-20 Jerome L. Shen An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
US5589182A (en) 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
US5463283A (en) 1994-05-24 1995-10-31 Bkl, Inc. Drive circuit for electroluminescent lamp
AU3689095A (en) 1994-10-03 1996-04-26 Schouten Industries B.V. Food and health products
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
IL115110A (en) 1995-08-30 1997-08-14 Chajuss Daniel Soy molasses
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
PL184852B1 (pl) * 1996-02-29 2002-12-31 Nutri Pharma As Kompozycja na bazie składników soi
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
PT906029E (pt) * 1996-04-09 2002-11-29 Du Pont Produto de proteina de soja enriquecido em isoflavona e metodo para o seu fabrico
WO1998003084A1 (en) 1996-07-18 1998-01-29 Nutricor, Inc. Nutritious food preparations and methods for making them
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
AU3218697A (en) 1997-01-21 1998-08-07 Minnesota Mining And Manufacturing Company Tubing for an ink delivery system
WO1998035699A1 (en) * 1997-02-12 1998-08-20 Nutri Pharma Asa Use of a combination of an anti-smoking composition and a dietary composition in smoking cessation
US5948814A (en) * 1997-02-20 1999-09-07 The Curators Of The University Of Missouri Genistein for the treatment of cystic fibrosis
DE69818594T2 (de) 1997-06-23 2004-09-23 Société des Produits Nestlé S.A. Verwendung einer nutritiven Zusammensetzung zur Herstellung einer flüssigen Zusammensetzung für Diabetiker
US5855892A (en) 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease

Also Published As

Publication number Publication date
BR9915689A (pt) 2002-10-08
US6509043B1 (en) 2003-01-21
DE69908809D1 (de) 2003-07-17
EP1133307A1 (de) 2001-09-19
HK1041634A1 (zh) 2002-07-19
AU1404600A (en) 2000-06-13
WO2000030664A1 (en) 2000-06-02
JP2002530346A (ja) 2002-09-17
EP1133307B1 (de) 2003-06-11
CA2352338A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
ATE242638T1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
DE69914947D1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen
ATE253925T1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
DE60220145D1 (de) Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
DE69827001D1 (de) Gewebedezellularization
ATE233558T1 (de) Verwendung von strontiumsälze zur behandlung von arthrose
ATE253921T1 (de) Kombinationen aus calzium und vitamin d
ES2152072T3 (es) Compuesto nutritivo mejorado resultado de la maceracion de maiz y su procedimiento de obtencion.
DE69328438D1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
DE69734405D1 (de) Verwendung von CS-866 (Olmersartan) zur Herstellung eines Medikaments für die Behandlung von Arteriosklerose
ATE35416T1 (de) Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
BR0210522A (pt) Processo para tratamento de carcaça de animal
ES2110550T3 (es) Tratamiento de la carne o del pescado.
ATE149832T1 (de) Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege
ZA858672B (en) New use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE60317178D1 (de) Verwendung einer wässrigen Lösung mit einem oder mehreren Bifluoriden zur Verbesserung des Trocknungsprozesses von Frischholz
ATE216842T1 (de) Hypoallergenischer instantbrei und verfahren zur herstellung
DE59208712D1 (de) Neue cytarabin-derivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties